Abstract
The process of autoantibody production in systemic lupus erythematosus is characterized by findings of both an antigen-driven response and polyclonal B-cell activation. Autoantibody production does not appear to be critically dependent on the presence of the CD5$U+ B cell subset. Increasing evidence supports a role for T helper cell type 2 cytokines, such as interleukin-4 and interleukin-6, in promoting and perpetuating B-cell hyperactivity and autoantibody formation.
| Original language | English |
|---|---|
| Pages (from-to) | 570-574 |
| Number of pages | 5 |
| Journal | Current Opinion in Rheumatology |
| Volume | 5 |
| Issue number | 5 |
| DOIs | |
| State | Published - 1993 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver